Edwards Lifesciences (EW) Free Cash Flow Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.94 Bn | 194.34 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 129.96 Bn | 126.49 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 120.01 Bn | 110.79 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.40 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.63 Bn | 32.68 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 34.02 Bn | 31.91 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | -14.34% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 19.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 142.84% |
| Mar 31, 2026 | -109.40% |
| Dec 31, 2025 | 299.38% |
| Sep 30, 2025 | 72.12% |
| Jun 30, 2025 | -15.80% |
| Mar 31, 2025 | 288.89% |
| Dec 31, 2024 | -467.08% |
| Sep 30, 2024 | -15.81% |
| Jun 30, 2024 | 2,100.70% |
| Mar 31, 2024 | -147.03% |
| Dec 31, 2023 | -77.42% |
| Sep 30, 2023 | 42.48% |
| Jun 30, 2023 | -104.95% |
| Mar 31, 2023 | 14.51% |
| Dec 31, 2022 | -24.63% |
| Sep 30, 2022 | -46.94% |
| Jun 30, 2022 | -36.71% |
| Mar 31, 2022 | 13.42% |
| Dec 31, 2021 | -0.98% |
| Sep 30, 2021 | 317.73% |